These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 24331438)

  • 1. The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the science and implications for the Asia-Pacific region.
    Amico KR
    Sex Health; 2014 Jul; 11(2):155-65. PubMed ID: 24331438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region.
    Lo YR; Kato M; Phanuphak N; Fujita M; Duc DB; Sopheap S; Pendse R; Yu D; Wu Z; Chariyalertsak S
    Sex Health; 2014 Jul; 11(2):126-36. PubMed ID: 25007911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
    Idoko J; Folayan MO
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.
    Fowler N; Arkell P; Abouyannis M; James C; Roberts L
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19563. PubMed ID: 25394070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call.
    Nachega JB; Uthman OA; Mills EJ; Quinn TC
    J AIDS Clin Res; 2013 Oct; 2012(Suppl 4):. PubMed ID: 24032088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
    Haire B; Kaldor JM
    Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
    Supervie V
    Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From modeling to morals: imagining the future of HIV PREP in Lesotho.
    Kenworthy NJ; Bulled N
    Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas.
    Holt M
    Sex Health; 2014 Jul; 11(2):166-70. PubMed ID: 23866853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.
    Amico KR
    Curr Opin HIV AIDS; 2012 Nov; 7(6):542-8. PubMed ID: 22964887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A community perspective on pre-exposure prophylaxis.
    Collins S
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19522. PubMed ID: 25394031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV treatment as prevention: population effect vs. individual protection?
    Ippolito G; Rezza G
    Ann Ig; 2013; 25(2):93-7. PubMed ID: 23471446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the benefit of the biomedical and behavioral interventions in preventing HIV transmission?
    Kuchenbecker R
    Rev Bras Epidemiol; 2015 Sep; 18 Suppl 1():26-42. PubMed ID: 26630297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
    Hankins CA; Dybul MR
    Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions.
    McNicholl JM
    Hum Vaccin Immunother; 2016 Dec; 12(12):3202-3211. PubMed ID: 27679928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Getting to zero' in Asia and the Pacific through more strategic use of antiretrovirals for HIV prevention.
    Cassell MM; Holtz TH; Wolfe MI; Hahn M; Prybylski D
    Sex Health; 2014 Jul; 11(2):107-18. PubMed ID: 24942266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bringing new HIV infections to zero - opportunities and challenges offered by antiretroviral-based prevention in Asia, the Pacific and beyond: An overview of this special issue.
    Zablotska IB; Whittaker B; de Wit J; Kamarulzaman A; Ananworanich J; Wright E; Poynten IM; Mayer K
    Sex Health; 2014 Jul; 11(2):97-100. PubMed ID: 25017549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we stop AIDS with antiretroviral-based treatment as prevention?
    Mills EJ; Nachega JB; Ford N
    Glob Health Sci Pract; 2013 Mar; 1(1):29-34. PubMed ID: 25276515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the HIV continuum of care following expanded access to HIV testing and treatment in Indonesia: A retrospective population-based cohort study.
    Tarigan YN; Woodman RJ; Miller ER; Wisaksana R; Wignall FS; Ward PR
    PLoS One; 2020; 15(9):e0239041. PubMed ID: 32915923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.